Objective: To describe hepatitis C virus (HCV) and HIV prevalence and co-infection, and to examine variables associated with infection in a community sample of men who have sex with men (MSM). Methods: Data were from an anonymous, cross-sectional study (N = 5080) in Canada. Men selfcompleted a questionnaire and provided an optional saliva specimen for HCV and HIV testing. Polytomous logistic regressions identified variables associated with HCV, HIV, and HCV-HIV coinfection. Results: The prevalences of HCV, HIV, and HCV-HIV co-infection were 1.9%, 9.0%, and 0.7%, respectively. The greatest contribution to HCV (odds ratio (OR) 23.66, 95% confidence interval (CI) 9.69-57.73) and HCV-HIV co-infection (OR 26.76,) was injection drug use. Sexual behaviors and proxies were associated with HIV but not HCV infection. Conclusions: Results suggest there are subgroups of MSM at risk for HCV. While sexual transmission of HCV was not ruled out, the predominant risk was needle sharing. The greater prevalence of HCV among HIV-positive men suggests the need for greater vigilance in the detection of HCV in this group. #
Introduction
Worldwide, few studies have been undertaken to determine the prevalence of hepatitis C virus (HCV) or to examine social and other behavioral risk factors associated with this infection in a community sample. Most HCV prevalence estimates have been derived from modeling of data from clinic and laboratory populations and through cohort studies.
1 Clinical and population-based studies have predominantly captured heterosexual populations and many have excluded known homosexual populations. Methods have not been designed to include marginalized and difficult to sample groups such as gay and bisexual men.
HCV prevalence varies greatly from country to country and from region to region. 1 It is estimated that one third of HIV-positive persons worldwide are co-infected with HCV. 2 While estimates of co-infection rates vary among 'at-risk' populations, co-infections occur most frequently among injection drug users (IDUs). [3] [4] [5] Concern about co-infection among HIV-infected populations exists for a number of reasons. HIV-infected people are more likely to be susceptible to HCV morbidity, 3 and co-infection is thought to accelerate HIV disease progression. Further, persons co-infected with HCV and HIV exhibit more rapid progression to liver cirrhosis and liver failure. [6] [7] [8] [9] [10] Available treatments for co-infection are challenging and complex. 2 Given what is known about transmission, research identifying HCV and HCV-HIV co-infection has mainly focused on IDUs. A large number of studies have shown that HCV prevalence among HIV-infected IDUs is higher than HIV-negative IDUs. Several studies have found increased prevalence of HCV among men who have sex with men (MSM) compared with the general population. [11] [12] [13] [14] [15] [16] [17] The contribution of sexual activities between gay and bisexual men to HCV transmission has been somewhat equivocal. [11] [12] [13] 18 There are a number of reasons why gay and bisexual male populations may be at risk for HCV. First, considerable drug use and potential mixing with injection drug using populations may place those in the gay community at risk for HCV. For example, in a study of gay and bisexual men who use drugs other than alcohol or marijuana, 52% reported needle use at least once in their lifetime. 19 Millson et al. (1995) reported that rates of HIV infection among male IDUs who have sex with men (29%) are higher than other male IDUs in a community sample (4.9%). 20 Second, with the repertoire of sexual activities practiced by gay and bisexual men, rectal trauma may result in an increased potential for direct exposure to blood. 21, 22 While Craib (2004) found the predominant factor associated with HCV infection among MSM to be injection drug use, he also identified the sexual practice of insertive fisting to be marginally associated with HCV seropositivity. 23 Rauch and colleagues have found unprotected anal intercourse to be associated with increased incidence of HCV infection among MSM. 26 The purpose of this study was to assess the prevalence of HCV and HCV-HIV co-infection in a community sample of gay and bisexual men. The specific objectives were to ascertain HCV prevalence, to examine the extent of coinfection with HIV, and to undertake investigations of variables and factors associated with HCV infection and HCV-HIV co-infection.
Methods

Study population
The data used for this analysis were from an anonymous, cross-sectional study of socio-behavioral issues and sexual health in a community sample of gay and bisexual men in Ontario, Canada. The survey was based in venues, including bars and bathhouses, and community groups in 13 cities/ regions. A purposive sampling strategy was utilized to recruit a diverse sample of gay and bisexual men.
Only men over the age of 15 years were included. Informed consent was obtained verbally from all participants prior to data collection. The study received approval from the University of Toronto Research Ethics Board.
Data collection
Data collection was conducted by trained coordinators and volunteer recruiters. A self-report questionnaire was available in seven languages (English, French, Chinese, Portuguese, Spanish, Tamil, and Vietnamese). The sampling strategy was developed prior to entry in the field through an assessment of the patterns of socialization (i.e., number of venues, groups, days of week for special events, etc.). Over 418 recruitment sessions, varied by day-of-week and time-of-day were conducted. The number of respondents recruited in each venue was determined by the venue size. A systematic sampling approach was utilized to ensure that individuals frequenting venues at different points in time were selected.
The questionnaire sought information on sociodemographic and personal characteristics, socialization, sexual health, patterns of partner seeking, sexual relationships, condom use, sexual behavior (lifetime, past 12 months, and past 3 months), substance use, and HIV testing. Upon completion of the questionnaire, respondents were given the option to provide a saliva specimen. The saliva specimen was collected with an Omni-Sal TM device. Completed anonymous questionnaires and saliva specimens were coded with unique identifiers prior to analysis.
Laboratory methods
HIV and HCV antibody testing were conducted at the Central Public Health Laboratory, Ontario Ministry of Health and Long-Term Care. The hepatitis C screen test was performed using the Ortho Diagnostic HCV 3.0 SAVe ELISA test kit and the confirmatory testing was performed using the Bio-Rad Monolisa anti-HCV Plus version 2. The sensitivity of the assay ranged from 72% to 88% and the specificity ranged from 89% to 100%. 25 Fluid specimens were tested for the HIV antibody using the Biochem Detect HIV v1 test kit, an enzyme linked immunoassay (ELISA). Reactive specimens were confirmed with the Vironostika HIV-1 Micro-ELISA system (bioMerieux, Organon Teknika). The Vironostika assay was sensitive (98.7%) and highly specific (100%). If the second test was not reactive (indeterminate or negative), the discrepancy was resolved using a Genetic Systems HIV-1 Western Blot (Bio-Rad). 
Data analysis
We carried out descriptive analyses of the sample including the distribution of key sociodemographic and personal characteristics, socialization, sexual health, sex life, and recreational drug use variables. Only participants providing sufficient saliva for testing were included in the univariate and multivariate analyses. Categorical variables were dummy coded. Univariate and multivariate polytomous logistic regressions were used to identify the variables associated with the presence of HCV infection only, HIV infection only, and HCV-HIV co-infection relative to individuals who had no infection. Crude odds ratios (COR), adjusted odds ratios (AOR), and 95% confidence intervals (CI) were calculated. A backward selection process was used to identify factors associated with the outcome. If the p-value of the variable was less than or equal to 0.20 in the univariate polytomous analysis, it was entered into the multivariate polytomous analysis. The significance level required for inclusion was set at 0.05. All analyses were performed using SAS, version 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Study sample characteristics
In total, 5080 men participated in the survey. Of these, 3635 (71.6%) participants provided saliva and 3304 (65.0%) of specimens collected contained sufficient fluid to conduct laboratory tests to detect the presence of both HCV and HIV antibodies. Table 1 compares the characteristics of the participants who provided sufficient saliva for HIV and HCV biological testing with the characteristics of those who did not provide saliva. The 331 (6.5%) men who provided saliva but whose saliva was not sufficient for HCV and HIV biological testing and who were excluded from univariate and multivariate analysis did not differ from men who had sufficient saliva. 
HCV, HIV, and HCV-HIV prevalence
In this sample, the overall HCV prevalence was 1.9% and the overall HIV prevalence was 9.0%. The prevalence rates of HCV infection only, HIV infection only, and HCV-HIV co-infection among men providing sufficient saliva (i.e., the sample examined in the regression analysis), were 1.2% (0.86-1.6%), 8.3% (7.4-9.3%), and 0.7% (0.41-0.98%), respectively. Table 2 presents the HCV, HIV, and HCV-HIV prevalence and prevalence ratios for various subgroups of individuals.
Univariate analyses
Univariate polytomous logistic regressions were undertaken to examine the relationship of sociodemographic and personal characteristics, socialization, sexual health, sex life, and drug use variables with HCV infection, HIV infection, and HCV-HIV co-infection (see Table 3 ).
Multivariate analyses
Multivariate polytomous logistic regressions were used to examine the associations among selected variables and HCV infection, HCV-HIV co-infection, and HIV infection individually in relation to no infection (see Table 4 ). In view of the cumulative nature of prevalence, infection was associated with increasing age in all three groupings (HCV infection, HCV-HIV co-infection, and HIV infection). HCV and HCV-HIV co-infection were not associated with education. However, HIV infection was less likely to be associated with those with graduate education compared to those with high school education or less. HCV-HIV coinfection as well as HIV infection were more likely to be found among those who were not in the labor force compared to those who were.
HCV, HIV, and HCV-HIV co-infection were not associated with gay bar or straight bar attendance. Men who attended bathhouses one to three times a month were more likely to be HIV-infected compared to those who never attended or attended bathhouses less than twice a year (AOR 2.03, 95% CI 1.49-2.76).
Similar to socializing variables, a number of sexually transmitted diseases (STDs) dropped out in the multivariate analysis. Nevertheless, urethral gonorrhea and genital or anal warts were associated with HIV infection. Men who had ever had hepatitis A virus (HAV) were more likely to be HCV-HIV coinfected compared to those who never had (AOR 16.64, 95% CI 4.17-66.36; p < 0.0001). This association is somewhat difficult to explain based simply on route of transmission. The main source of HAV transmission is fecal and the main source of transmission for HCV and HIV is through blood or semen, respectively. It is possible that individuals who are HCV-HIV co-infected may engage in a wider range of sexual activities, which may include oral-anal contact and oral sex, where HAV transmission is more likely to occur. Our data on unprotected oral, and oral-anal sex did not adequately permit us to examine this. Also, it is possible that HCV-HIV co-infection may accelerate the likelihood of becoming HAV-infected. Further, men who were ever infected with hepatitis B were more likely to be HIV-infected compared to others (AOR 1.98, 95% CI 1.24-3.14; p = 0.0040).
Unprotected receptive anal intercourse was associated with HIV infection (AOR 2.14, 95% CI 1.52-2.99; p < 0.0001) but not with HCV or HCV-HIV co-infection. Receipt of drugs, goods, clothing, protection, or shelter from a male in exchange for sex was not associated with HCV infection but was associated with HCV-HIV co-infection and HIV infection; and there was a stronger association with HCV-HIV coinfection (AOR 7.18, 95% CI 1.81-28.45; p = 0.0050) than HIV infection (AOR 2.38, 95% CI 1.41-4.00; p = 0.0011). Further, no associations were found for the receipt of money in exchange for sex.
Variables most strongly associated with HCV and HCV-HIV co-infection were recreational drug use and injection drug use. For injecting drugs, the respective AORs were 23.66 (95% CI 9.69-57.73; p < 0.0001) and 26.76 (95% CI 7.97-89.80; p < 0.0001). For recreational drug use, the respective AORs were 18.81 (95% CI 2.44-144.89; p = 0.0048) and 11.76 (95% CI 1.21-114.57; p = 0.0340).
Discussion
While HCV prevalence is thought to be higher in the general population than HIV prevalence, in this gay and bisexual community sample HCV prevalence was found to be lower than HIV prevalence. Although, in some regards, HCV infection may not be a major concern in the gay and bisexual community at large, the finding that HCV prevalence in the gay and bisexual community is slightly higher than in the general population in Canada suggests there may be concern for some subgroups of men, specifically MSM who are also recreational drug users and/or IDUs. In this analysis, the greatest contribution to HCV infection and HCV-HIV coinfection were injection and recreational drug use. Personal income, ethnicity, sexual identity, gay bar attendance, and professional sex work (i.e., sex for money) were not associated with HCV infection in this analysis. Sex for drugs or goods may be a corollary for drug use. 24, 25 Sexual behaviors and proxies for sexual risk behavior, such as STDs, were associated with HIV infection but not HCV infection.
In Canada, the HCV prevalence in the population at large was estimated to be 0.8% in 2002. 27 The HCV prevalence for the USA population at large has been estimated to be 1.8%. 28 The overall HCV prevalence for men in this sample was 1.9%. Based on the male population in Ontario, we calculated the age standardized prevalence rate for our sample to be 1.7%, which is higher than the estimated rate of 1.14% for the total male population of the province. 29 No estimates of the HCV prevalence in a community sample of gay and bisexual men in Canada have been previously available. Internationally, information on the prevalence of HCV among gay and bisexual men suggests it may range from 3% to 14%, which demonstrates considerable variation in HCV infection by country and sampling frame. 1, 11, 18, 30, 31 In this community sample, we found that HCV prevalence was higher among HIV-positive men compared to HIV-negative men, but was lower among self-identified gay and bisexual men compared with those with other identities. Univariate analysis suggests associations between sexual identity (gay/bisexual versus other) and HCV infection; however, these associations disappeared in the multivariate analysis. Despite the lifetime prevalence, this suggests self-identified gay and bisexual men may not be at increased risk for HCV infection.
The overall HCV-HIV co-infection prevalence among men in our analysis was 0.7%. In our sample among HIV-positive individuals, 7.7% were HCV-positive, and among HCV-positive individuals 35.9% were HIV-positive. In Canada, a study conducted in an HIV laboratory in Alberta found a prevalence of 9.3% among 54 HIV-positive men; 32 another study in general practice clinics in Vancouver reported an HCV rate of infection of 8.8% among 352 HIV-infected men; 33 and a cohort study of HIV-negative MSM conducted in Montreal reported an HCV prevalence of 2.9%. 34 In a review of 15 international studies of HCV-HIV co-infection among MSM, the rates of coinfection ranged from 0% to 14%. In the current study, 5.7% reported ever using needles to inject recreational drugs. This study confirms that injection drug use is the predominant mode of HCV infection and HCV-HIV co-infection among the men in the sample, which agrees with the results found in Europe, Australia, and the USA. 14, [35] [36] [37] [38] [39] Our data on related risk factors show an association between STDs, a proxy for lifetime sexual behavior, specifically urethral gonorrhea and genital or anal warts, and HIV infection but not HCV infection. There are equivocal data regarding the association between the number of sex partners and HCV infection. 32, 40, 41 In this analysis, an association was found with the number of sexual partners in the univariate analysis but not in the multivariate analysis. Further, HCV-HIV co-infection differed between some subpopulations. Additional study of the differences between subpopulations is important. 25, 26 In our analysis, HIV-positive men were 5.5 times more likely to be HCV-infected compared to those who were HIVnegative. This may suggest that HCV is associated with specific sexual behaviors among people who are HIV-infected and perhaps the increased vulnerability to HCV infection among those who are HIV-positive. The finding of this analysis is consistent with the results that have been found in European studies, which have shown outbreaks of HCV among MSM who have high-risk sexual behaviors. [42] [43] [44] [45] In this sample of gay and bisexual men, more than half took recreational drugs. Longitudinal studies are needed to investigate and confirm the sexual risk of HCV transmission among HIV-infected people, especially those who are not IDUs.
There are limitations to our findings. Because the study was cross-sectional, we could not determine when the men acquired HIV and HCV, which presents challenges to the understanding of causal relationships. Additional studies using a prospective design are necessary to clarify the predictors of infection. The survey results relied on self-report data. Therefore, as participants retrospectively report their behavior, there may be inaccuracies in reporting lifetime behavior. The study recruitment was primarily venue-based. Methods were varied to ensure a broad and diverse sample, but there may have been some community sectors who were not represented or who were underrepresented. Also, our study did not examine several identified sexual risk behaviors for HCV infection among MSM, such as fisting. 46 Our study provides important initial insights to be considered for targeting and enhancing existing prevention, surveillance, and care initiatives. Due to the lack of an effective vaccine for either HCV or HIV infection, increased awareness, education, screening, and health services are needed to help reduce disease transmission and infection. 47 Identifying individuals who could benefit from behavioral and medical intervention is vital in the effort to reduce HCV, HIV, and HCV-HIV co-infection.
Our results suggest that within the gay and bisexual community there are subgroups of men for whom HCV infection is a concern. This study confirms findings of other studies, which indicate needle sharing to be the major mode of transmission of HCV. The sexual transmission of HCV, if any, would seem to account for a very small proportion of HCV infections. Testing and counseling programs should clearly distinguish between the risks for transmission of HCV and HIV infection. Care for HIV-infected people needs to emphasize the prevention of HCV infection and motivate MSM who are HIV-positive to practice safer sex because of the additional risk that may exist in transmitting and acquiring HCV infection. Clearly, for some men, such as men who may have few options but to exchange sex for their survival, more structural and program supports are needed. Programs for MSM need to consider some of the essential components of harm reduction and provide options for addiction treatment for those who require it.
